scholarly journals Hepatitis E virus replication involves alternating negative- and positive-sense RNA synthesis

2010 ◽  
Vol 92 (3) ◽  
pp. 572-581 ◽  
Author(s):  
S. P. K. Varma ◽  
A. Kumar ◽  
N. Kapur ◽  
H. Durgapal ◽  
S. K. Acharya ◽  
...  
2018 ◽  
Vol 154 (3) ◽  
pp. 663-674.e7 ◽  
Author(s):  
Xianfang Wu ◽  
Viet Loan Dao Thi ◽  
Peng Liu ◽  
Constantin N. Takacs ◽  
Kuanhui Xiang ◽  
...  

2015 ◽  
Vol 120 ◽  
pp. 134-139 ◽  
Author(s):  
Yuchen Nan ◽  
Zexu Ma ◽  
Harilakshmi Kannan ◽  
David A. Stein ◽  
Patrick I. Iversen ◽  
...  

2016 ◽  
Vol 64 (2) ◽  
pp. S518
Author(s):  
L. Xu ◽  
W. Wang ◽  
X. Zhou ◽  
Y. Wang ◽  
Y. Yin ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Zhubing Li ◽  
Lu Chen ◽  
Qiang Liu

Hepatitis E virus (HEV) is a small nonenveloped single-stranded positive-sense RNA virus and is one of the major causes for acute hepatitis worldwide. CXCL-8 is a small multifunctional proinflammatory chemokine. It was reported recently that HEV infection significantly upregulates CXCL-8 gene expression. In this study, we investigated the mechanism of HEV-induced CXCL-8 transcriptional activation. Using CXCL-8 promoter reporters of different lengths ranging from −1400 to −173, we showed that −173 promoter has the highest promoter activity in the presence of HEV genomic RNA, indicating that the −173 promoter contains sequences responsible for CXCL-8 activation by HEV. Ectopic expression of the ORF-1 protein can upregulate the −173 CXCL-8 promoter activity. In contrast, expression of the ORF-2 protein suppresses the CXCL-8 promoter activity and expression of the ORF-3 protein has no effect on the CXCL-8 promoter activity. We further showed that AP-1 is required for CXCL-8 activation because neither HEV genomic RNA nor the ORF-1 protein can upregulate the −173 CXCL-8 promoter in the absence of the AP-1 binding sequence. Taken together, our results showed that HEV and HEV ORF-1 protein activate the CXCL-8 promoter via AP-1. This novel function of HEV ORF-1 protein should contribute to our understanding of HEV-host interactions and HEV-associated pathogenesis.


2010 ◽  
Vol 84 (18) ◽  
pp. 9637-9641 ◽  
Author(s):  
Yogesh A. Karpe ◽  
Kavita S. Lole

ABSTRACT Hepatitis E virus (HEV) has a positive-sense RNA genome with a 5′-m7G cap. HEV open reading frame 1 (ORF1) encodes a polyprotein with multiple enzyme domains required for replication. HEV helicase is a nucleoside triphosphatase (NTPase) with the ability to unwind RNA duplexes in the 5′-to-3′ direction. When incubated with 5′-[γ-32P]RNA and 5′-[α-32P]RNA, HEV helicase released 32P only from 5′-[γ-32P]RNA, showing specificity for the γ-β-triphosphate bond. Removal of γ-phosphate from the 5′ end of the primary transcripts (pppRNA to ppRNA) by RNA triphosphatase is an essential step during cap formation. It is suggested that HEV employs the helicase to mediate the first step of 5′ cap synthesis.


2017 ◽  
Vol 66 (1) ◽  
pp. S471-S472
Author(s):  
C. Qu ◽  
W. Wang ◽  
L. Xu ◽  
Y. Yin ◽  
Q. Pan ◽  
...  

2021 ◽  
Author(s):  
Changbo Qu ◽  
Yang Li ◽  
Yunlong Li ◽  
Yihang Pan

Abstract Hepatitis E virus (HEV) infection is the leading cause of acute hepatitis worldwide. Mitochondrial antiviral signaling protein (MAVS)-mediated interferon (IFN) response plays a pivotal role in the hepatic antiviral immunity. However, little is known about the effects of overexpression of MAVS on HEV infection. Here, we studied the effects of FL-MAVS on HEV. We found that overexpression of FL-MAVS profoundly inhibited HEV replication. The overexpression of FL-MAVS is accompanied by the secretion of functional IFNs and transcriptional induction of interferon stimulated genes (ISGs). Furthermore, we showed that the anti-HEV effect of FL-MAVS is largely dependent of the JAK signaling activation.


1999 ◽  
Vol 73 (10) ◽  
pp. 8848-8850 ◽  
Author(s):  
Yamina Kabrane-Lazizi ◽  
Xiang-Jin Meng ◽  
Robert H. Purcell ◽  
Suzanne U. Emerson

ABSTRACT Hepatitis E virus (HEV) is an unclassified virus with a positive-sense RNA genome and an undefined replication strategy. In order to determine whether the HEV genome is capped or not, we developed a reverse transcription-PCR assay that is based on the ability of a monoclonal antibody to recognize 7-methylguanosine (m7G). Antibody to m7G bound RNA extracted from virions of two different HEV genotypes. The cap analog competitively inhibited the binding of virion RNAs, demonstrating that HEV has a capped RNA genome.


Sign in / Sign up

Export Citation Format

Share Document